Compare TECH & EXLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TECH | EXLS |
|---|---|---|
| Founded | 1976 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 5.1B |
| IPO Year | 1995 | 2004 |
| Metric | TECH | EXLS |
|---|---|---|
| Price | $50.89 | $30.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $73.09 | $46.80 |
| AVG Volume (30 Days) | ★ 2.2M | 2.1M |
| Earning Date | 05-06-2026 | 04-28-2026 |
| Dividend Yield | ★ 0.62% | N/A |
| EPS Growth | N/A | ★ 27.27 |
| EPS | 0.49 | ★ 1.54 |
| Revenue | $1,219,635,000.00 | ★ $2,087,679,000.00 |
| Revenue This Year | $2.49 | $12.85 |
| Revenue Next Year | $6.40 | $10.65 |
| P/E Ratio | $105.65 | ★ $19.98 |
| Revenue Growth | 5.23 | ★ 13.56 |
| 52 Week Low | $46.02 | $26.94 |
| 52 Week High | $72.16 | $48.79 |
| Indicator | TECH | EXLS |
|---|---|---|
| Relative Strength Index (RSI) | 37.52 | 44.73 |
| Support Level | $51.00 | $28.62 |
| Resistance Level | $54.08 | $32.98 |
| Average True Range (ATR) | 2.32 | 0.97 |
| MACD | -0.05 | 0.27 |
| Stochastic Oscillator | 31.01 | 44.85 |
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
ExlService Holdings Inc. is a data analytics and digital operations company that provides data and AI-led solutions and technology-enabled services to clients across industries. The company has four reportable segments. The Insurance segment provides services such as claims management, underwriting support, and analytics solutions. The Healthcare and Life Sciences segment offers data-driven solutions and services to healthcare payers, providers, and life sciences organizations. The Banking, Capital Markets and Diversified Industries segment delivers solutions across financial services and other industries. The International Growth Markets segment focuses on providing data, AI, and digital operations services to clients outside North America.